| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |